A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2

NCT04766307 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
1100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing Chest Hospital